ClinicalTrials.govpublic full text
The Efficacy and Safety of Treatment with Telitacicept in Antineutrophil Cytoplasmic Antibody-associated Nephritis (AAGN)
antineutrophil cytoplasmic antibody (anca)-associated nephritis (aagn), anca-associated nephritis, anca, antineutrophil cytoplasmic antibody (anca)-associated vasculitis, aagn, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 890770
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.